Australia markets closed

argenx SE (ARGX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
393.72-4.87 (-1.22%)
At close: 04:00PM EDT
393.72 0.00 (0.00%)
After hours: 04:01PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close398.59
Open397.61
Bid394.06 x 200
Ask394.97 x 200
Day's range391.70 - 397.79
52-week range327.73 - 550.76
Volume184,199
Avg. volume349,801
Market cap23.348B
Beta (5Y monthly)0.35
PE ratio (TTM)N/A
EPS (TTM)-5.14
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est478.76
  • Insider Monkey

    Here’s Why argenx SE (ARGX) Pulled Back 23% in Q4

    TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” fourth-quarter investor letter. A copy of the same can be downloaded here. In the fourth quarter, the strategy underperformed the Russell Midcap Growth Index and returned 13.66% (gross) and 13.44% (net) while the index return was -14.55%. In addition, please check […]

  • GlobeNewswire

    argenx Advances Clinical Development of Efgartigimod in Primary Sjogren’s Disease

    RHO study supports proof-of-concept in primary Sjogren’s disease Decision informed by favorable safety profile and consistency across efficacy and biomarker measures March 27, 2024, 7:00 AM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced its plan to continue the development of efgartigimod to Phase 3 in adults with primary Sjogren’s disease (SjD)

  • GlobeNewswire

    argenx Announces Annual General Meeting of Shareholders on May 7, 2024

    March 26, 2024 Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that the Annual General Meeting of shareholders will be held at 13:00 CET on Tuesday, May 7, 2024 at the Hilton Amsterdam Schiphol at Schiphol Boulevard 701, 1118 BN Schiphol, the Netherlands.The shareholders and all other persons with meeting rights are invited to attend the Annual Gener